Skip to Main Content

Author Details

Robert S Welner
University of Alabama at Birmingham
2002
71
27
Jake Y. Chen (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36413413Low c-Kit expression identifies primitive, therapy-resistant CML stem cells.JCI Insight2023
36413413Low c-Kit expression identifies primitive, therapy-resistant CML stem cells.JCI Insight2023
37336880Author Correction: The IL-33-PIN1-IRAK-M axis is critical for type 2 immunity in IL-33-induced allergic airway inflammation.Nat Commun2023
37020962Pancreatic islet cell type-specific transcriptomic changes during pregnancy and postpartum.iScience2023
37192295Metabolic adaptation to tyrosine kinase inhibition in leukemia stem cells.Blood2023
36550214Microenvironmental CXCL12 deletion enhances Flt3-ITD acute myeloid leukemia stem cell response to therapy by reducing p38 MAPK signaling.Leukemia2023
37058110Hedgehog Signaling Regulates Treg to Th17 Conversion Through Metabolic Rewiring in Breast Cancer.Cancer Immunol Res2023
37192295Metabolic adaptation to tyrosine kinase inhibition in leukemia stem cells.Blood2023
37058110Hedgehog Signaling Regulates Treg to Th17 Conversion Through Metabolic Rewiring in Breast Cancer.Cancer Immunol Res2023
37020962Pancreatic islet cell type-specific transcriptomic changes during pregnancy and postpartum.iScience2023
37336880Author Correction: The IL-33-PIN1-IRAK-M axis is critical for type 2 immunity in IL-33-induced allergic airway inflammation.Nat Commun2023
36550214Microenvironmental CXCL12 deletion enhances Flt3-ITD acute myeloid leukemia stem cell response to therapy by reducing p38 MAPK signaling.Leukemia2023
34808021Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms.Cancer Sci2022
36220999Autophagy inhibition impairs leukemia stem cell function in FLT3-ITD AML but has antagonistic interactions with tyrosine kinase inhibition.Leukemia2022
35756656Deciphering Metabolic Adaptability of Leukemic Stem Cells.Front Oncol2022
36407327WINNER: A network biology tool for biomolecular characterization and prioritization.Front Big Data2022
36115580Ex Vivo Expansion of Phenotypic and Transcriptomic Chronic Myeloid Leukemia Stem Cells.Exp Hematol2022
34520730Serine-threonine Kinase Receptor-Associated Protein is a Critical Mediator of APC Mutation-Induced Intestinal Tumorigenesis Through a Feed-Forward Mechanism.Gastroenterology2022
34857894Isocitrate dehydrogenase mutations are associated with altered IL-1β responses in acute myeloid leukemia.Leukemia2022
35263572Response to NK cell content does not seem to influence engraftment in ex vivo T cell depleted haploidentical stem cell transplantation.Stem Cell Reports2022
34808021Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms.Cancer Sci2022
35756656Deciphering Metabolic Adaptability of Leukemic Stem Cells.Front Oncol2022
36407327WINNER: A network biology tool for biomolecular characterization and prioritization.Front Big Data2022
36220999Autophagy inhibition impairs leukemia stem cell function in FLT3-ITD AML but has antagonistic interactions with tyrosine kinase inhibition.Leukemia2022
36115580Ex Vivo Expansion of Phenotypic and Transcriptomic Chronic Myeloid Leukemia Stem Cells.Exp Hematol2022
34857894Isocitrate dehydrogenase mutations are associated with altered IL-1β responses in acute myeloid leukemia.Leukemia2022
35263572Response to NK cell content does not seem to influence engraftment in ex vivo T cell depleted haploidentical stem cell transplantation.Stem Cell Reports2022
34520730Serine-threonine Kinase Receptor-Associated Protein is a Critical Mediator of APC Mutation-Induced Intestinal Tumorigenesis Through a Feed-Forward Mechanism.Gastroenterology2022
34260914TNF-α-induced alterations in stromal progenitors enhance leukemic stem cell growth via CXCR2 signaling.Cell Rep2021
34242616Improved hematopoietic stem cell transplantation upon inhibition of natural killer cell-derived interferon-gamma.Stem Cell Reports2021
33857288PU.1 enforces quiescence and limits hematopoietic stem cell expansion during inflammatory stress.J Exp Med2021
34120146Metabolic alterations mediated by STAT3 promotes drug persistence in CML.Leukemia2021
33854168Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer.Commun Biol2021
34010414Core-binding factor leukemia hijacks the T-cell-prone PU.1 antisense promoter.Blood2021
34260914TNF-α-induced alterations in stromal progenitors enhance leukemic stem cell growth via CXCR2 signaling.Cell Rep2021
33547048E-cadherin is regulated by GATA-2 and marks the early commitment of mouse hematopoietic progenitors to the basophil and mast cell fates.Sci Immunol2021
34804065Inflammatory Cytokines Shape an Altered Immune Response During Myeloid Malignancies.Front Immunol2021
33854168Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer.Commun Biol2021
33547048E-cadherin is regulated by GATA-2 and marks the early commitment of mouse hematopoietic progenitors to the basophil and mast cell fates.Sci Immunol2021
33857288PU.1 enforces quiescence and limits hematopoietic stem cell expansion during inflammatory stress.J Exp Med2021
34804065Inflammatory Cytokines Shape an Altered Immune Response During Myeloid Malignancies.Front Immunol2021
34242616Improved hematopoietic stem cell transplantation upon inhibition of natural killer cell-derived interferon-gamma.Stem Cell Reports2021
34120146Metabolic alterations mediated by STAT3 promotes drug persistence in CML.Leukemia2021
34010414Core-binding factor leukemia hijacks the T-cell-prone PU.1 antisense promoter.Blood2021
32542325Lysine acetyltransferase Tip60 is required for hematopoietic stem cell maintenance.Blood2020
33208555Bone marrow Tregs mediate stromal cell function and support hematopoiesis via IL-10.JCI Insight2020
32542325Lysine acetyltransferase Tip60 is required for hematopoietic stem cell maintenance.Blood2020
32641586Selective LXR agonist DMHCA corrects retinal and bone marrow dysfunction in type 2 diabetes.JCI Insight2020
32553173Single-Cell RNA-Seq Mapping of Human Thymopoiesis Reveals Lineage Specification Trajectories and a Commitment Spectrum in T Cell Development.Immunity2020
33208555Bone marrow Tregs mediate stromal cell function and support hematopoiesis via IL-10.JCI Insight2020
  • 1 - 50 of 142

Recommended Authors

University of Toronto
Career Start Year 2006
Number of shared co-authors 0
NYU Robert I. Grossman School of Medicine
Career Start Year 2006
Number of shared co-authors 4
Graduate School of Medicine, The University of Tokyo
Career Start Year 2004
Number of shared co-authors 0
South China University of Technology
Career Start Year 2003
Number of shared co-authors 2
Karolinska Institutet
Career Start Year 2003
Number of shared co-authors 2
McGill University
Career Start Year 2003
Number of shared co-authors 0
University of Washington
Career Start Year 2002
Number of shared co-authors 1
Institute for Research in Immunology and Cancer, University of Montreal
Career Start Year 2000
Number of shared co-authors 0
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 2000
Number of shared co-authors 0
Tokyo University of Science
Career Start Year 1999
Number of shared co-authors 0
Children's Hospital of Philadelphia
Career Start Year 1999
Number of shared co-authors 0
Oregon Health & Science University
Career Start Year 1999
Number of shared co-authors 1
Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 3
University of California Irvine
Career Start Year 1998
Number of shared co-authors 0
Smilow Cancer Center, Yale University School of Medicine
Career Start Year 1997
Number of shared co-authors 0
Joslin Diabetes Center
Career Start Year 1996
Number of shared co-authors 1
and Blood Institute, National Institutes of Health
Career Start Year 1996
Number of shared co-authors 0
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year 1992
Number of shared co-authors 5
Institute for Life and Medical Sciences, Kyoto University
Career Start Year 1991
Number of shared co-authors 0
MRC Weatherall Institute of Molecular Medicine, University of Oxford
Career Start Year 1990
Number of shared co-authors 4
St. Jude Children's Research Hospital
Career Start Year 1989
Number of shared co-authors 1
Universite de Montreal
Career Start Year 1988
Number of shared co-authors 2
The University of Tokyo.
Career Start Year 1984
Number of shared co-authors 0
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 1
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 0
Boston Children's Hospital, Harvard Medical School
Career Start Year 1982
Number of shared co-authors 5
Department of Biomedical Science and Center for Bio-Nanomaterials, Daegu University
Career Start Year 1981
Number of shared co-authors 2
Advanced Research Institute, Tokyo Medical and Dental University
Career Start Year 1981
Number of shared co-authors 1
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1980
Number of shared co-authors 2
Center for Stem Cell Biology & Regenerative Medicine and.
Career Start Year 1976
Number of shared co-authors 1

Collaborators

Harvard Stem Cell Institute, Harvard Medical School
Co-authored papers 24
Cancer Science Institute of Singapore, National University of Singapore
Co-authored papers 10
The University of Alabama at Birmingham School of Medicine
Co-authored papers 10
Boston Children's Hospital, Harvard Medical School
Co-authored papers 6
University of Alabama at Birmingham
Co-authored papers 6
University of Alabama at Birmingham
Co-authored papers 5
University of Alabama at Birmingham
Co-authored papers 4
Cancer Science Institute of Singapore, National University of Singapore
Co-authored papers 4
Dana-Farber Cancer Institute, Harvard Medical School
Co-authored papers 3
Vanderbilt University
Co-authored papers 3
University of Alabama at Birmingham
Co-authored papers 3
Co-authored papers 2
University of Colorado Anschutz Medical Campus
Co-authored papers 2
University of Alabama at Birmingham
Co-authored papers 2
Co-authored papers 2
University of Colorado Anschutz Medical Campus
Co-authored papers 2
Beth Israel Deaconess Medical Center
Co-authored papers 2
Co-authored papers 2
University of Alabama at Birmingham
Co-authored papers 2
Cancer Institute of Singapore, National University of Singapore
Co-authored papers 2
Co-authored papers 2
University of Alabama at Birmingham, USA Informatics Institute
Co-authored papers 2
Vita-Salute San Raffaele University
Co-authored papers 1
Co-authored papers 1
O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham
Co-authored papers 1
Research Institute of Molecular Pathology
Co-authored papers 1
O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham
Co-authored papers 1
University of Alabama at Birmingham
Co-authored papers 1
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School
Co-authored papers 1